TOPIC

/ company

Sino Biopharmaceutical

Sino Biopharmaceutical develops, manufactures and markets pharmaceuticals, biopharmaceuticals and Chinese medicines. It offers products to treat conditions ranging from hepatitis to respiratory and digestive diseases. It is a subsidiary of Thailand's Charoen Pokphand Group.

Chairman / President

Theresa Tse

CEO / Managing Director

Tse, Eric S Y

CFO / Finance Director

Li Chunling

Industry

Pharmaceuticals

Website

sinobiopharm.com

Headquarters address

Unit 09, 41/F, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong

Stock Code

SEHK:1177

Year founded

2000

Global investors have reaped sizeable rewards from their investments in Hong Kong-listed biotech and pharmaceutical companies in the past year. Photo: Shutterstock

Banking & finance

Global funds, from BlackRock to Temasek, back China’s largest biotech firms

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne.

23 Jan 2026 - 8:30AM

Hong Kong stock market

Hong Kong stocks edge higher on last full trading day of year

30 Dec 2025 - 4:33PM

Made in China 2025

China’s pharmaceutical industry transforms into a global innovation powerhouse

19 Dec 2025 - 8:30AM

Biomedicine: Industry Trends

China’s drug developers stretch to become a global force

Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms, experts say.

4 Oct 2025 - 10:56AM

Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

11 Sep 2025 - 4:43PM

Hong Kong stock market

Hong Kong stocks rise on China policy hopes after soft economic data

China’s industrial output and fixed-asset investment fell short in May, and the downturn in the property market deepened.

16 Jun 2025 - 4:40PM

Hong Kong stock market

Hong Kong stocks fall on rising geopolitical tensions

Israel launches air strikes targeting both nuclear and military sites and officials leading Iran’s nuclear programme.

13 Jun 2025 - 4:43PM

A man passes a foreign exchange shop in Hong Kong. Photo: Reuters

Hong Kong stock market

Hong Kong stocks fall on US trade threats and interest rate uncertainty

US President Donald Trump says he will unveil unilateral tariff rates within two weeks.

12 Jun 2025 - 4:42PM

Science

US approves China-invented painkiller that could reduce fentanyl overdoses

Qamzova is a non-steroidal anti-inflammatory that provides 24-hour pain relief in a single shot, reducing post-surgery opioid reliance.

23 May 2025 - 7:00PMvideocam

Hong Kong stock market

China’s first rate cut in 7 months drives Hong Kong stocks to 2-month high

Lower borrowing costs will be a major driver for stocks, Guotai Haitong Securities analysts Fang Yi says.

20 May 2025 - 4:35PM

General view of Exchange Square in Central. Photo: Jelly Tse

Science

Drug trial offers hope for patients with hard-to-treat lung cancer in China, US

New medication appears to be safer and more effective than standard therapy, according to trial led by Chinese and US scientists.

12 May 2025 - 3:24PMvideocam

Lung cancer is the most prevalent type of the disease worldwide, with an estimated 2.5 million new cases globally last year. Photo: PR NEWSWIRE

Coronavirus pandemic

Sino Biopharm invests US$515 million in Sinovac’s Covid-19 vaccine unit

Beijing-based generic drug maker buys 15 per cent stake in Sinovac Life Sciences, a unit of Nasdaq-listed pharmaceutical firm Sinovac Biotech.

14 Dec 2020 - 6:13PMvideocam

Stocks

Stocks Blog: China stocks gain ahead of global financial leaders' teleconference call on coronavirus

Reuters reports draft statement of G7 leaders does not include specific, coordinated steps. That led to a pullback in Asia markets. In Hong Kong, Tencent, Ping An Good Doctor, China Tobacco International gained. In China, Kweichow Moutai advanced.

3 Mar 2020 - 6:19PM

Hang Seng Index

Sino Biopharmaceutical added to Hong Kong index amid Beijing biotech push

An index that tracks shares of mainland Chinese companies on the Hong Kong stock exchange will admit a pharmaceutical stock and a utility. The companies replace a railway company and a building materials producer, partly reflecting the changing profile of China’s economy.

9 Nov 2019 - 9:00AM

Sino Biopharmaceutical’s inclusion in the Hang Seng China Enterprises Index boosts Eric Tse, who recent became the company’s largest shareholder. Photo: Instagram

Wealth management

Eric Tse, Rihanna’s selfie mate, is instant tycoon on US$3.8 billion gift

The share transfer is the latest in the tsunami of Asian wealth that’s being passed down to the next generation. In 2018, four Chinese tycoons tipped more than US$17 billion into family trusts, while many of Hong Kong’s biggest developers are going through succession planning.

24 Oct 2019 - 5:36PM

A self picture of Eric Tse with Rihanna. Photo: Instagram @erictse0816